These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17642044)

  • 21. The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
    Miller JM; Pliskin NH
    Int J Neurosci; 2006 May; 116(5):613-27. PubMed ID: 16644521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gray-matter degeneration in presenile Alzheimer's disease.
    Prohovnik I; Smith G; Sackeim HA; Mayeux R; Stern Y
    Ann Neurol; 1989 Feb; 25(2):117-24. PubMed ID: 2919865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular dementia and Alzheimer's disease: the unsolved problem of clinical and neuropsychological differential diagnosis.
    Misciagna S; Masullo C; Giordano A; Silveri MC
    Int J Neurosci; 2005 Dec; 115(12):1657-67. PubMed ID: 16287632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Symptom severity and symptom progression in Alzheimer's disease-- comparison between two cases with early and late onset].
    Haupt M; Kurz A; Pollmann S; Romero B
    Nervenarzt; 1992 Sep; 63(9):561-5. PubMed ID: 1407227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Greater impairment of ability in the divided attention task is seen in Alzheimer's disease patients with depression than in those without depression.
    Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Hirono N; Furukawa TA
    Dement Geriatr Cogn Disord; 2007; 23(4):231-40. PubMed ID: 17308387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.
    Cortes F; Nourhashémi F; Guérin O; Cantet C; Gillette-Guyonnet S; Andrieu S; Ousset PJ; Vellas B;
    Alzheimers Dement; 2008 Jan; 4(1):22-9. PubMed ID: 18631947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression.
    Holthoff VA; Beuthien-Baumann B; Kalbe E; Lüdecke S; Lenz O; Zündorf G; Spirling S; Schierz K; Winiecki P; Sorbi S; Herholz K
    Biol Psychiatry; 2005 Feb; 57(4):412-21. PubMed ID: 15705358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence and comorbidity of neuropsychiatric symptoms in Alzheimer's disease].
    García-Alberca JM; Pablo Lara J; González-Barón S; Barbancho MA; Porta D; Berthier M
    Actas Esp Psiquiatr; 2008; 36(5):265-70. PubMed ID: 18597200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of a neuropathologically verified familial Alzheimer's cohort with onset in the fourth decade: comparison with senile onset Alzheimer's disease and etiopathogenic implications.
    Reisberg B; Ferris SH; Franssen E; Jenkins EC; Wisniewski KE
    Prog Clin Biol Res; 1989; 317():43-54. PubMed ID: 2690108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early symptoms and neurological findings in demented subjects from a community survey.
    Torres HA; Fratiglioni L; Hofman W; Winblad B
    Alzheimer Dis Assoc Disord; 1995; 9(3):170-5. PubMed ID: 8534416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of the Bender Gestalt Test for differentiation of dementia with Lewy bodies from Alzheimer's disease in patients showing mild to moderate dementia.
    Murayama N; Iseki E; Yamamoto R; Kimura M; Eto K; Arai H
    Dement Geriatr Cogn Disord; 2007; 23(4):258-63. PubMed ID: 17351317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality of life in Alzheimer's disease].
    Baquero M; Peset V; Burguera JA; Salazar-Cifre A; Boscá-Blasco ME; del Olmo-Rodríguez A; Valero-Merino C; Muñoz-Lacalle RA;
    Rev Neurol; 2009 Oct 1-15; 49(7):337-42. PubMed ID: 19774526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease.
    Geerlings MI; den Heijer T; Koudstaal PJ; Hofman A; Breteler MM
    Neurology; 2008 Apr; 70(15):1258-64. PubMed ID: 18391157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychologic variables in sporadic late-onset Alzheimer disease in patients of spanish nationality: a fast and efficient assessment procedure.
    Sánchez JL; Rodríguez M; Carro J
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Sep; 15(3):207-15. PubMed ID: 12218714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical profiles of late-onset semantic dementia, compared with early-onset semantic dementia and late-onset Alzheimer's disease.
    Shimizu H; Komori K; Fukuhara R; Shinagawa S; Toyota Y; Kashibayashi T; Sonobe N; Matsumoto T; Mori T; Ishikawa T; Hokoishi K; Tanimukai S; Ueno S; Ikeda M
    Psychogeriatrics; 2011 Mar; 11(1):46-53. PubMed ID: 21447109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity and reliability of the newly translated Hellenic Neuropsychiatric Inventory (H-NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic.
    Politis AM; Mayer LS; Passa M; Maillis A; Lyketsos CG
    Int J Geriatr Psychiatry; 2004 Mar; 19(3):203-8. PubMed ID: 15027034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alzheimer's disease and depression].
    Gallarda T
    Encephale; 1999 Nov; 25 Spec No 5():14-7; discussion 18. PubMed ID: 10609097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical heterogeneity of Alzheimer's disease. Different clinical profiles can predict the progression rate].
    Mangone CA
    Rev Neurol; 2004 Apr 1-15; 38(7):675-81. PubMed ID: 15098191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.